13. 多発性硬化症／視神経脊髄炎 ［臨床試験数：3,050，薬物数：2,147（DrugBank：348），標的遺伝子数：244，標的パスウェイ数：228］
Searched query = "Multiple sclerosis", "Neuromyelitis optica", "MS", "NMOSD", "Devic disease", "Balo concentric sclerosis", "Baló concentric sclerosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|1||NCT01381354||October 2010||26/5/2011||Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)||Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)||Multiple Sclerosis||Other: Progressive exercise;Device: Neuromuscular electrical stimulation delivered using the electrical therapy device EMPI 300 PV;Other: Modified paleolithic diet;Dietary Supplement: Omega 3 fatty acids;Dietary Supplement: Full Spectrum vitamin;Dietary Supplement: Essential - hydroxytyrosol;Dietary Supplement: Maltodextrin fiber supplement;Dietary Supplement: Mineral boost (magnesium);Dietary Supplement: Niacinamide;Dietary Supplement: Methyl B12;Dietary Supplement: Taurine;Dietary Supplement: creatine;Dietary Supplement: thiamine;Dietary Supplement: riboflavin;Dietary Supplement: N acetylcysteine;Dietary Supplement: alpha lipoic acid;Dietary Supplement: L acetyl carnitine;Dietary Supplement: methyl folate;Dietary Supplement: coenzyme Q;Behavioral: meditation;Behavioral: self massage;Behavioral: learning;Dietary Supplement: Coconut oil||University of Iowa||Direct MS Canada;DJO Incorporated;Pinnaclife Inc.;TZ Press, LLC||Completed||18 Years||65 Years||All||38||Phase 1||United States|
|2||EUCTR2008-000955-90-IT||24/04/2007||12/03/2008||Randomized, single-blind, clinical and MRI study for evaluation of safety and efficacy of N-Acetyl Cysteine (NAC) associated with high-dose beta-Interferon in Relapsing-Remitting (RR) multiple sclerosis patients - renac||Randomized, single-blind, clinical and MRI study for evaluation of safety and efficacy of N-Acetyl Cysteine (NAC) associated with high-dose beta-Interferon in Relapsing-Remitting (RR) multiple sclerosis patients - renac||multiple sclerosis |
MedDRA version: 9.1Level: HLTClassification code 10052785Term: Multiple sclerosis acute and progressive
|Product Name: n-acetylcysteine|
INN or Proposed INN: Acetylcysteine
|ISTITUTO C. MONDINO||NULL||Authorised-recruitment may be ongoing or finished||Female: yes|
|3||NCT00203099||December 2004||13/9/2005||Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine||A Pilot, Multicenter, Open-label, One-group Study to Explore the Efficacy, Tolerability and Safety of the Combination of Glatiramer Acetate (GA) and N-Acetylcysteine (NAC) in Subjects With Relapsing Remitting Multiple Sclerosis (RR-MS)||Relapse Remitting Multiple Sclerosis||Drug: Glatiramer Acetate, N-Acetylcysteine||Teva Pharmaceutical Industries||NULL||Completed||18 Years||50 Years||Both||18||Phase 2||Canada|